The<unk> (DAIS) is a double-blinded placebo-controlled study that assessed the rate of cardiovascular disease following the administration of 200 mg fenofibrate in non-insulin-dependent diabetes subjects.
Diabetes Atherosclerosis Intervention Study 
Stockholm Ischemic Heart Disease Study
Antihypertensive and lipid-lowering treatment to prevent heart attack trial
Chronic stable angina COURAGE trial
Diabetes mellitus type 2 Cost-Effectiveness of Therapy
Niacin AIM HIGH study
ASPEN Trial
Clopidogrel dosing and role of genetics: ELEVATE-TIMI 56 trial